A Phase 1 Study of NUV-1511 in People With Advanced Breast Cancer

Full Title

Purpose

In this study, researchers want to find the best dose of NUV-1511 to use in people with advanced breast cancer. The people in this study have breast cancer that has metastasized (spread) or keeps growing even with treatment.

NUV-1511 is a multi-target drug. This means it can affect several other molecules, such as proteins, and may cause cancer cells to die. It is given intravenously (by vein).

Who Can Join

To join this study, there are a few conditions. You must:

• Have breast cancer that has metastasized or keeps growing despite treatment 
• Have completed previous breast cancer treatment at least 2 weeks before getting NUV-1511.
• Be able to walk and do routine activities for more than half the time you are awake.
• Be age 18 or older.

Contact

For more information or to see if you can join this study, please call Dr. Shanu Modi’s office at 646-888-4564.